ARTICLE | Company News
Alnylam, Silence Therapeutics, BASF, Merck, Pfizer chemistry news
December 13, 2010 8:00 AM UTC
Alnylam said the Opposition Division of the European Patent Office (EPO) upheld European Patent No. EP1407044, part of the company's Tuschl II estate. The patent covers compositions, methods and uses ...